CUSTOMIZED SOUND THERAPY (CST)
Device Facts
| Record ID | K070599 |
|---|---|
| Device Name | CUSTOMIZED SOUND THERAPY (CST) |
| Applicant | Tinnitus Otosound Products, LLC |
| Product Code | KLW · Ear, Nose, Throat |
| Decision Date | Jul 13, 2007 |
| Decision | SESE |
| Submission Type | Abbreviated |
| Regulation | 21 CFR 874.3400 |
| Device Class | Class 2 |
| Attributes | Software as a Medical Device, Therapeutic |
Indications for Use
The TOP-LLC CST is intended for use by a qualified healthcare professional such as an otolaryngologist, an audiologist, or other qualified professional. It is intended to mask or intermittently mask the patient's tinnitus as part of a tinnitus management program. Patients receive a medical evaluation by a licensed physician (preferably a physician who specializes in diseases of the ear) to rule out medically or surgically treatable diseases for which tinnitus is a symptom before proceeding with CST. Initial hearing and tinnitus tests are conducted by a qualified audiologist familiar with the treatment of timitus; subsequent management of the treatment is carried out by an audiologist or other qualified professional.
Device Story
CST is software-based tinnitus management system; operates on standard Windows PC. Clinician uses proprietary GUI and cmusic acoustic compiler to generate sounds matching patient's tinnitus based on verbal feedback. Matching sound file written to PC hard drive; transferred to patient's portable audio device (PAD). Patient uses PAD volume control to adjust sound level to match tinnitus sensation for temporary relief. Used in clinical setting by audiologists/otolaryngologists; patient uses PAD for home therapy. Benefits include temporary masking of tinnitus disturbance.
Clinical Evidence
No clinical data provided. Substantial equivalence based on technological characteristics and intended use compared to predicate devices.
Technological Characteristics
Software-based system; utilizes cmusic acoustic compiler. Runs on Windows XP (SP2) PC (1.2 GHz CPU, 256 MB RAM). Outputs sound files to portable audio devices (PAD). No specialized hardware; uses commercially available computer/audio equipment.
Indications for Use
Indicated for adults (18+) with tinnitus, with or without high-frequency hearing loss, participating in a tinnitus management program. Requires medical evaluation to rule out treatable underlying conditions.
Regulatory Classification
Identification
A tinnitus masker is an electronic device intended to generate noise of sufficient intensity and bandwidth to mask ringing in the ears or internal head noises. Because the device is able to mask internal noises, it is also used as an aid in hearing external noises and speech.
Special Controls
The special control for this device is patient labeling regarding:(1) Hearing health care professional diagnosis, fitting of the device, and followup care, (2) Risks, (3) Benefits, (4) Warnings for safe use, and (5) Specifications.
Predicate Devices
Reference Devices
- Elements of Computer Music (Moore, 1990)
- Long-term reductions in tinnitus severity (Folmer, 2002)
Submission Summary (Full Text)
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image shows the text "K070599" in a handwritten style. Below this, the text "JUL 13 2007" is printed in a simple, sans-serif font. The text appears to be part of a document or label, possibly indicating a date or identification number.
#### 510K Summary
APPLICANT: ADDRESS:
#### CONTACTS:
Geraldine Crean, Ph.D. Regulatory Liaison, Tinnitus Otosound Products, LLC gerldinecrean@yahoo.com 310-927-6151
Anthony Materna, Ph.D. CEO, Tinnitus Otosound Products, LLC tmaterna@top llc.net
Tinnitus Otosound Products, LLC
880 First Street, Suite 403
Los Angeles, CA 90012
#### DATE OF SUBMISSION:
February 28, 2007
310-273-8217
213-626-0927
#### TRADE OR PROPRIETARY NAME: Customized Sound Therapy
## COMMON OR UNUSUAL NAME(S): CST
#### CLASSIFICATION NAME:
Tinnitus Masker Device (TMD) Described in 21 CFR 874.3400 Class II, product code KLW
{1}------------------------------------------------
## PREDICATE DEVICE(S)
Petroff Audio Technologies, Inc. Manufacturer: Tradename: Dynamic Tinnitus Mitigation System, DTM-6 510K Number: K974501
Manufacturer: Neuromonics (formerly TiniTech) Tradename: TinniTech ANMP System 510K Number: K030791
## SUBSTANTIAL EQUIVALENCE
Customized Sound Therapy is claiming substantial equivalence to two devices.
1. Equivalence to the Dynamic Timitus Mitigation System, DTM-6, manufactured by Petroff Audio Technologies Inc. 510K number K974501.
2. Equivalence is also claimed to the TinniTech ANMP System, manufactured by Neuromonics (formerly TiniTech). 510K number K030791
## DEVICE DESCRIPTION
The Tinnitus Otosound Products LLC (TOP-LLC), Customized Sound Therapy (CST), falls under devices described in 21 CFR 874.3400 Class II, product code KLW. The device is a CD comprised of software with two components: a graphic user interface and cmusic program. The software can be used on a notebook or desktop computer with at least Windows XP (SP2) having at least a 1.2 GHz Pentium III CPU (or equivalent), 256 MB of RAM, 1 GB of free disk space, a CD drive, and an available USB port.
The Customized Sound Therapy software produces, and transfers sounds to a sound wave file. This sound file can be stored on any commercially available computer hard drive or portable audio device (PAD) like an iPod.
{2}------------------------------------------------
## DESCRIPTION OF DEVICE DESIGN
The CST software consists of specialized programs for creating the CST sounds, which are matched as closely as possible to the tinnitus sensation experienced by the patient. The CST software is based on the cmusic acoustic compiler and a proprietary graphic user interface developed specifically for use during sound matching with CST [1; Chapter 3, pp. 150-214; Appendix D, pp. 490-546]. - Under control of a qualified audiologist or other qualified professional, the CST software writes the matching sound on the hard drive of the computer. A copy of this sound is transferred to a commercially available portable audio device for use by the patient during therapy. The volume control on the PAD is used to match that apparent level of the CST sound to the patient's tinnitus sensation as subjectively judged by the patient.
The system is intended to provide relief from the disturbance of tinnitus in an attempt to provide temporary relief of the effect of tinnitus
#### INTENDED USE
The TOP-LLC CST is intended for use by a qualified healthcare professional such as an otolaryngologist, an audiologist, or other qualified professional. It is intended to mask or intermittently mask the patient's tinnitus as part of a tinnitus management program.
Patients receive a medical evaluation by a licensed physician (preferably a physician who specializes in diseases of the ear) to rule out medically or surgically treatable diseases for which tinnitus is a symptom before proceeding with CST. Initial hearing and tinnitus tests are conducted by a qualified audiologist familiar with the treatment of timitus; subsequent management of the treatment is carried out by an audiologist or other qualified professional.
{3}------------------------------------------------
## INDICATIONS FOR USE
The CST system is a CD with software that enables qualified professional to identify, with the patient's verbal input, the sounds that most closely match the patient's tinnitus. The device is indicated to mask and intermittently mask tinnitus as part of a tinnitus management program. The target population for the device is adults (18 years and over) who present with tinnitus, that may or may not be accompanied with hearing loss at the higher frequencies, and who are participating in a tinnitus management program.
#### RISKS AND WARNINGS FOR SAFE USE
The software packaging and the CD are clearly marked with two warnings: 1) the sounds on the discs should not be played at uncomfortable levels, and 2) the CST system should not be used if such use prevents the user from hearing sounds warning of danger (like the beeping of oncoming vehicles).
The following caution statement is also on the software packaging and the CD:
Caution: Federal law restricts this device to sale by or on the order of a practitioner licensed by the law of the State in which he/she practices to use or order the use of this device.
## DEVICE CHARACTERISTICS
The CST device consists of computer software, which identifies, produces and transfers custom sounds, CST, from a desktop or laptop to a PAD. The CST software is based on the cmusic acoustic compiler (standard in generating computer music) that includes a proprietary graphic user interface developed specifically for use during sound matching with CST [1]. CST software will be use with standard computer and audio equipment that is commercially available. The standard commercially available components are intended for use as designated by the manufacturer.
{4}------------------------------------------------
# CONCLUSIONS
CST is equivalent to tinnitus masking devices already approved for marketing.
## REFERENCES
[1] Moore, F. R. Elements of Computer Music (Prentice-Hall, 1990)
[2} Folmer, R.L. Long-term reductions in tinnitus severity. BMC Ear, Nose, and Throat Disorders, 2002, 2(3): 1-9.
{5}------------------------------------------------
Image /page/5/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized symbol that resembles three human profiles facing to the right, stacked on top of each other.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUL 1 3 2007
Tinnitus Otosound Products, LLC c/o Geraldine Crean, Ph.D. 880 First Street, Suite 403 Los Angeles, CA 90012
Re: K070599
Trade/Device Name: Customized Sound Therapy (CST) Regulation Number: 21 CFR 874.3400 Regulation Name: Tinnitus masker Regulatory Class: Class II Product Code: KLW Dated: May 22, 2007 Received: May 24, 2007
Dear Dr. Crean:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
{6}------------------------------------------------
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
M.B. Egleston, MD
Malvina B. Eydelman, M.D. Director Division of Ophthalmic and Ear. Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{7}------------------------------------------------
# Indications for Use
KOZOS 510(k) Number: "
Device Name: Customized Sound Therapy (CST)
Indicaitons For Use:
The CST system is a CD with software that enables a qualified healthcare professional to identify, with the patient's verbal input, the sounds that most closely match the patient's tinnitus. The device is indicated to mask and intermittently mask tinnitus as part of a tinnitus management program. The target population for the device is adults (18 years and over) who present with timitus, that may or may not be accompanied with hearing loss at the higher frequencies, and who are participating in a tinnitus management program.
Perscription Use: X (Part 21 CFR 801 Subpart D) AND/OR
Over-The Counter Use
(Part 21 CFR 801 Subpart D)
(12 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Drug Evaluation (ODE)
\$\checkmark\$
Prescription rescription of CFR 801.109) Page 1 of
Elm Chen Peng
(Division Sign-Off)
Division of Ophthalmic Ear,
Division of Ophthalmic Ear,
Nose and Throat Devises
510(k) Number K01054
